pseudohypoparathyroidism type 1A
pseudohypoparathyroidism type 1A
Explore linked clinical trials. Standard reference: MONDO:00070784 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Theophylline for Treatment of Pseudohypoparathyroidism | Bone Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, bone disorder, calcium metabolic disease, hereditary disease, inborn errors of metabolism, inborn metal metabolism disorder, metabolic disease, musculoskeletal system disorder, pseudohypoparathyroidism, pseudohypoparathyroidism type 1A | Enrolling by invitation | Phase 2 | 2026-09-02 | NCT04240821 | |
| Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a) | Body Weight, Bone Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, bone disorder, calcium metabolic disease, hereditary disease, inborn errors of metabolism, inborn metal metabolism disorder, metabolic disease, musculoskeletal system disorder, nutritional disorder, obesity disorder, overnutrition, pseudohypoparathyroidism, pseudohypoparathyroidism type 1A | Enrolling by invitation | Phase 2 | 2026-07-23 | NCT07496463 | |
| Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments | Bone Diseases, Developmental, Bone Diseases, Endocrine, Bone Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, Nutritional and Metabolic Diseases, bone disorder, brain disorder, calcium metabolic disease, central nervous system disorder, endocrine system disorder, hereditary disease, hypopituitarism, hypothalamic disorder, inborn errors of metabolism, inborn metal metabolism disorder, metabolic disease, musculoskeletal system disorder, nervous system disorder, pituitary dwarfism, pituitary gland disorder, pseudohypoparathyroidism, pseudohypoparathyroidism type 1A, pseudopseudohypoparathyroidism | Active, not recruiting | Not applicable | 2026-06-02 | NCT00209235 | |
| Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old | Bone Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, bone disorder, calcium metabolic disease, hereditary disease, inborn errors of metabolism, inborn metal metabolism disorder, metabolic disease, musculoskeletal system disorder, pseudohypoparathyroidism, pseudohypoparathyroidism type 1A | Active, not recruiting | Phase 2 | 2026-04-29 | NCT04551170 |